Product Information

LANSOPRAZOLE DR 15 MG ODT is a generic product labeled by Aurobindo Pharma Limited, priced at $1.7023 per EA under NDC 65862089578. Its NADAC has been published 154 times since Dec 13, 2023.

FDA first approved this application on Mar 28, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the Lansoprazole market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

LANSOPRAZOLE DR 15 MG ODT

Lansoprazole
$1.7023per EA
High Outlier

Strength

15 mg/1

NDC

65862089578

Classification

Generic

Dosage Form

TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

LANSOPRAZOLE

Approval Type

Generic (ANDA)

FDA Application

ANDA207167

FDA Approved

3/28/2023

TE Code

AB

On Market Since

3/28/2023

Pharmacological Classes

Inhibition Gastric Acid Secretion
Proton Pump Inhibitor
Proton Pump Inhibitors

Price Statistics

The NADAC for LANSOPRAZOLE DR 15 MG ODT has been published 154 times since Dec 13, 2023, and over the history we have for it it has declined 52.7%. The table below summarizes its recorded NADAC range and movement.

Current price$1.7023 per EA
All-time high$4.7198 (Mar 13, 2024)
All-time low$1.5080 (Apr 22, 2026)
52-week high$1.9563
52-week low$1.5080
Median price$1.9563
Average price$2.2748
Largest weekly change+65.3% (Feb 21, 2024)
Weeks tracked154
Tracking sinceDec 13, 2023

Price History

1W

-13.0%

1M

-11.4%

3M

-9.2%

6M

+8.7%

1Y

+3.8%

3Y

N/A

5Y

N/A

All

-52.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of LANSOPRAZOLE DR 15 MG ODT?

The current National Average Drug Acquisition Cost (NADAC) for LANSOPRAZOLE DR 15 MG ODT, manufactured by Aurobindo Pharma Limited, is $1.7023 per EA (NDC 65862089578), effective Nov 18, 2026.

How has the price of LANSOPRAZOLE DR 15 MG ODT changed over time?

Over the history we have for it, the NADAC for LANSOPRAZOLE DR 15 MG ODT has declined 52.7%. It has been tracked across 154 weekly CMS publications since Dec 13, 2023.

What are the highest and lowest recorded NADAC prices for LANSOPRAZOLE DR 15 MG ODT?

Since Dec 13, 2023, the NADAC for LANSOPRAZOLE DR 15 MG ODT has ranged from a low of $1.5080 (Apr 22, 2026) to a high of $4.7198 (Mar 13, 2024), with a median of $1.9563 per EA.

Are there cheaper alternatives to LANSOPRAZOLE DR 15 MG ODT?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as LANSOPRAZOLE DR 15 MG ODT in a comparable dosage form, but none are currently priced below it.

Who manufactures LANSOPRAZOLE DR 15 MG ODT?

LANSOPRAZOLE DR 15 MG ODT (NDC 65862089578) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.